Boardroom Alpha
Start trial
10-K primary document
CLOV · Annual Report (Form 10-K) · Filed February 27, 2026

Clover Health Investments Corp — 10-K exhibit

a10-k2025exx23.htm
Clover Health Investments Corp on Boardroom Alpha
Document
Exhibit 23
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
1.Registration Statement on Form S-3 (Registration No. 333-264801) of Clover Health Investments, Corp.;
2.Registration Statement on Form S-8 (Registration No. 333-254947) pertaining to the 2020 Equity Incentive Plan of Clover Health Investments, Corp., 2020 Employee Stock Purchase Plan, of Clover Health Investments, Corp. and the Amended and Restated 2014 Equity Incentive Plan of Clover Health Investments, Corp.;
3.Registration Statement on Form S-8 (Registration No. 333-278316) pertaining to the registration of additional shares of Class A common stock under the 2020 Equity Incentive Plan of Clover Health Investments, Corp. and 2020 Employee Stock Purchase Plan, of Clover Health Investments, Corp.;
4.Registration Statement on Form S-8 (Registration No. 333-285638) pertaining to the registration of additional shares of Class A common stock under the 2020 Equity Incentive Plan of Clover Health Investments, Corp. of Clover Health Investments, Corp.;
5.Registration Statement on Form S-8 (Registration No. 333-263401) pertaining to the registration of additional shares of Class A common stock under the 2020 Equity Incentive Plan of Clover Health Investments, Corp. and 2020 Employee Stock Purchase Plan, of Clover Health Investments, Corp.;
6.Registration Statement on Form S-8 (Registration No. 333-270395) pertaining to the registration of additional shares of Class A common stock under the 2020 Equity Incentive Plan of Clover Health Investments, Corp. and the 2020 Employee Stock Purchase Plan, of Clover Health Investments, Corp. and
7.Registration Statement on Form S-8 (Registration No. 333-263403) pertaining to the 2022 Inducement Award Plan of Clover Health Investments, Corp.
of our reports dated February 27, 2026, with respect to the consolidated financial statements of Clover Health Investments, Corp. and the effectiveness of internal control over financial reporting of Clover Health Investments, Corp. included in this Annual Report (Form 10-K) of Clover Health Investments, Corp. for the year ended December 31, 2025.
/s/ Ernst & Young LLP
New York, New York
February 27, 2026

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer